Position in GH
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,875,375
+$1,057,901 QoQ
Shares Held
12,500
+41.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
#266
of 594 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Yorktown Management & Research Co Inc holds $4,944,899 across 7 Diagnostics & Research names. GH ranks #1 (37.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
This page
|
12,500 | $1,875,375 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
1,800 | $953,262 | |
| 3 | TWST |
Twist Bioscience Corp
|
5,100 | $524,688 | |
| 4 | VCYT |
Veracyte, Inc.
|
7,750 | $455,157 | |
| 5 | BLLN |
BillionToOne, Inc.
|
3,450 | $413,931 | |
| 6 | GRAL |
GRAIL, Inc.
|
5,750 | $392,552 | |
| 7 | RDNT |
RadNet, Inc.
|
5,350 | $329,934 |
All Filings in GH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,875,375 | 12,500 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $817,474 | 8,850 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $566,877 | 5,550 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $346,764 | 5,550 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $288,822 | 5,550 | Shares | Sole | 2025-08-04 | |
| No filing history on record for this holder in this stock. | ||||||